These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F, Mouret-Reynier MA, Kwiatkowski F, Maublant J, Tchirkov A, Dauplat J. Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507 [Abstract] [Full Text] [Related]
4. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. Reitsamer R, Peintinger F, Rettenbacher L, Prokop E. J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778 [Abstract] [Full Text] [Related]
9. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy. Mustać E, Matusan-Ilijas K, Marijić B, Smokvina M, Jonjić N. Int J Surg Pathol; 2010 Feb 15; 18(1):36-41. PubMed ID: 19448065 [Abstract] [Full Text] [Related]
10. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L. J Am Coll Surg; 2009 Mar 15; 208(3):333-40. PubMed ID: 19317993 [Abstract] [Full Text] [Related]
11. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F. J Surg Oncol; 2004 Mar 15; 85(3):102-11. PubMed ID: 14991881 [Abstract] [Full Text] [Related]
13. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND. Goyal A, Newcombe RG, Chhabra A, Mansel RE. Ann Surg Oncol; 2008 Jan 15; 15(1):262-7. PubMed ID: 17879117 [Abstract] [Full Text] [Related]
14. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Jones JL, Zabicki K, Christian RL, Gadd MA, Hughes KS, Lesnikoski BA, Rhei E, Specht MC, Dominguez FJ, Smith BL. Am J Surg; 2005 Oct 15; 190(4):517-20. PubMed ID: 16164912 [Abstract] [Full Text] [Related]
16. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M. Ann Surg Oncol; 2009 Dec 15; 16(12):3366-74. PubMed ID: 19760047 [Abstract] [Full Text] [Related]
17. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy. Rebollo-Aguirre AC, Gallego-Peinado M, Menjón-Beltrán S, García-García J, Pastor-Pons E, Chamorro-Santos CE, Ramos-Font C, Salamanca-Ballesteros A, Llamas-Elvira JM, Olea-Serrano N. Rev Esp Med Nucl Imagen Mol; 2012 Dec 15; 31(3):117-23. PubMed ID: 21676504 [Abstract] [Full Text] [Related]
18. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Changsri C, Prakash S, Sandweiss L, Bose S. Breast J; 2004 Dec 15; 10(5):392-7. PubMed ID: 15327491 [Abstract] [Full Text] [Related]
20. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node. Yegiyants S, Romero LM, Haigh PI, DiFronzo LA. Arch Surg; 2010 Jun 15; 145(6):564-9. PubMed ID: 20566977 [Abstract] [Full Text] [Related] Page: [Next] [New Search]